Showing results (1971-1980 of 2,008) with videos related to

Sort By:
Pageof 201
Mymensingh Medical Journal : MMJ|November 30, 2018
Response of Proliferative Lupus Nephritis with Pulse Cyclophosphamide Therapy during Induction Period: A Single Centre Study in BangladeshM B Hossain, M F Khan, E F Ansary, et al.
Elife|April 22, 2020
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanomaKenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
A unified network systems approach uncovers a core novel program underlying T follicular helper cell differentiationAlisa A Omelchenko, Syed A Rahman, Vinayak V Viswanadham, et al.
Sleep|May 21, 2019
Effects on resident work hours, sleep duration, and work experience in a randomized order safety trial evaluating resident-physician schedules (ROSTERS)Laura K Barger, Jason P Sullivan, Terri Blackwell, et al.
Journal of Medical Microbiology|May 16, 2022
Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settingsPeter V Coyle, Naema Hassan Al Molawi, Mohamed Ali Ben Hadj Kacem, et al.
The New England Journal of Medicine|June 25, 2020
Effect on Patient Safety of a Resident Physician Schedule without 24-Hour ShiftsChristopher P Landrigan, Shadab A Rahman, Jason P Sullivan, et al.
Pediatrics|February 23, 2021
Extended Work Shifts and Neurobehavioral Performance in Resident-PhysiciansShadab A Rahman, Jason P Sullivan, Laura K Barger, et al.
Medicine|October 1, 2022
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trialAlaa Rahhal, Mostafa Najim, Amer Hussein Aljundi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trialF Griesinger, G Curigliano, M Thomas, et al.
Neuro-Oncology|April 17, 2021
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastomaMatthias Schneider, Lea Vollmer, Anna-Laura Potthoff, et al.
Pageof 201